SOL-GEL TECHNOLOGIES LTD (SLGL) Stock News

USA - NASDAQ:SLGL - IL0011417206 - Common Stock

30.47 USD

-0.16 (-0.52%)

Last: 11/10/2025, 2:10:23 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

SLGL Latest News, Press Relases and Analysis

All

Press Releases

3 days ago - By: Benzinga - Mentions: TNDM GMED WORX NTLA ...

12 Health Care Stocks Moving In Friday's Intraday Session

14 days ago - By: Benzinga - Mentions: CRS EL RNA GKOS ...

Booking Holdings To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Monday

3 months ago - By: Sol-Gel Technologies Ltd.

Sol-Gel Reports Second Quarter 2025 Financial Results and Provides Corporate Updates

6 months ago - By: Stocktwits

Sol-Gel Stock Tumbles Over Underwhelming Q1 Earnings: Retail Stays Pessimistic

6 months ago - By: Sol-Gel Technologies Ltd.

Sol-Gel Reports First Quarter 2025 Results

a year ago - By: BusinessInsider

News Image

SLGL Stock Earnings: Sol-Gel Technologies Beats EPS, Beats Revenue for Q2 2024

a year ago - By: Sol-Gel Technologies Ltd.

Sol-Gel Technologies Announces Management Realignment

7 months ago - By: Sol-Gel Technologies Ltd.

Sol-Gel and Mayne Pharma Announce the Purchase of EPSOLAY® and TWYNEO® in the U.S.

a year ago - By: Sol-Gel Technologies Ltd.

Sol-Gel Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Requirement

a year ago - By: Sol-Gel Technologies Ltd.

Sol-Gel Reports Third Quarter 2024 Financial Results and Provides Corporate Updates

a year ago - By: Sol-Gel Technologies Ltd.

UPDATE: Sol-Gel Reports Second Quarter 2024 Financial Results and Provides Corporate Updates

a year ago - By: BusinessInsider

News Image

SLGL Stock Earnings: Sol-Gel Technologies Misses EPS, Misses Revenue for Q1 2024

a year ago - By: InvestorPlace

SLGL Stock Earnings: Sol-Gel Technologies Beats EPS, Beats Revenue for Q2 2024

a year ago - By: Sol-Gel Technologies Ltd.

Sol-Gel Reports Second Quarter 2024 Financial Results and Provides Corporate Updates

a year ago - By: InvestorPlace

SLGL Stock Earnings: Sol-Gel Technologies Misses EPS, Misses Revenue for Q1 2024

a year ago - By: Sol-Gel Technologies Ltd.

Sol-Gel Reports First Quarter 2024 Financial Results and Provides Corporate Updates

1 years ago - By: Sol-Gel Technologies Ltd.

Sol-Gel and Beimei Pharma Announce an Asset Purchase Agreement to Commercialize TWYNEO® in the Mainland of China, Hong Kong, Macau, Taiwan and Israel

2 years ago - By: Sol-Gel Technologies Ltd.

Sol-Gel’s Collaboration Partner First-to-File ANDA Drug Product Generic to Zoryve® Cream

2 years ago - By: Sol-Gel Technologies Ltd.

Sol-Gel Reports Full-Year 2023 Financial Results and Corporate Developments

2 years ago - By: Sol-Gel Technologies Ltd.

Sol-Gel Technologies Screens First Patient for SGT-610 Phase 3 Study

2 years ago - By: Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd to Host Virtual KOL Event on Gorlin Syndrome and the Upcoming Phase 3 Trial for SGT-610

2 years ago - By: Sol-Gel Technologies Ltd.

Sol-Gel Technologies Reports Third Quarter 2023 Financial Results and Provides Corporate Update

2 years ago - By: Sol-Gel Technologies Ltd.

Sol-Gel Technologies Reports Second Quarter 2023 Financial Results and Provides Corporate Update

2 years ago - By: Seeking Alpha

Israel's Sol-Gel signs Canadian licensing deal for Twyneo, Eposolay (SLGL)

2 years ago - By: Sol-Gel Technologies Ltd.

Sol-Gel and Searchlight Pharma Announce Licensing Agreements to Commercialize TWYNEO® and EPSOLAY® in Canada

3 years ago - By: Sol-Gel Technologies Ltd.

Sol-Gel Technologies Reports First Quarter 2023 Financial Results and Provides Corporate Update

3 years ago - By: Sol-Gel Technologies Ltd.

Sol-Gel Technologies to Present at the H.C. Wainwright Autoimmune & Inflammatory Disease Virtual Conference